Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys-Reference-Cited by-同舟云学术

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

Published:2008-11-09 Issue:7225 Volume:457 Page:87-91
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Liu Jinyan,O’Brien Kara L.,Lynch Diana M.,Simmons Nathaniel L.,La Porte Annalena,Riggs Ambryice M.,Abbink Peter,Coffey Rory T.,Grandpre Lauren E.,Seaman Michael S.,Landucci Gary,Forthal Donald N.,Montefiori David C.,Carville Angela,Mansfield Keith G.,Havenga Menzo J.,Pau Maria G.,Goudsmit Jaap,Barouch Dan H.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature07469.pdf

Reference30 articles.

1. Fauci, A. S. The release of new data from the HVTN 502 (STEP) HIV vaccine study. National Institutes of Health (NIH) News, November 7. (2007)

2. Fauci, A. S. 25 years of HIV. Nature 453, 289–290 (2008)

3. Casimiro, D. R. et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79, 15547–15555 (2005)

4. Shiver, J. W. et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331–335 (2002)

5. Shiver, J. W. & Emini, E. A. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 55, 355–372 (2004)

Cited by 408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials and recent progress in HIV vaccine development;Functional & Integrative Genomics;2024-08-28

2. Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial;eBioMedicine;2024-02

3. Associated technologies for genome editing;Livestock Genome Editing Tools;2024

4. Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys;npj Vaccines;2023-11-10

5. Recent advances in CD8+ T cell-based immune therapies for HIV cure;Heliyon;2023-06